3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Recurrence
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Lymphoma, Large B-Cell, Diffuse
4
Neoplasms
3
Lymphoma, Non-Hodgkin
3
Lymphoma, B-Cell
3
Multiple Myeloma
2
Lymphoma, Mantle-Cell
2
Leukemia, Myeloid, Acute
2
Breast Neoplasms
2
Plasmacytoma
1
Nasopharyngeal Carcinoma
1
Meningeal Carcinomatosis
1
Lymphoma
1
Liver Neoplasms
1
Leukemia
1
Glioma
1
Carcinoma, Hepatocellular
1
Burkitt Lymphoma
1
Brain Neoplasms
1
Interventions
Cyclophosphamide
5
ibrutinib
4
fludarabine
4
pirtobrutinib
3
obinutuzumab
3
acalabrutinib
3
fludarabine phosphate
2
Rituximab
2
Mesna
2
venetoclax
1
ricolinostat
1
idelalisib
1
Whole-Body Irradiation
1
Vincristine
1
Tacrolimus
1
Stem Cell Transplantation
1
Prednisone
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
Mycophenolic Acid
1
Melphalan
1
Leukapheresis
1
Doxorubicin
1
Diet
1
Busulfan
1
Bone Marrow Transplantation
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, B-Cell
×
Immunotherapy, Adoptive
×
90 days
×
Clear all
No trials found.